Interstitial Lung Disease Archives - MPR

Interstitial Lung Disease

Drug-Device Promising in PH-ILD

Bellerophon Therapeutics announced positive topline results from cohort 2 of an ongoing phase 2/3 iNO-PF study of INOpulse (pulsed, inhaled nitric oxide) delivery system for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD). The INOpulse delivery system is designed to deliver inhaled nitric oxide via a proprietary triple-lumen nasal cannula directly to…